| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | STAB2 DSG3 PCLO PCDHA6 MATN4 ADGRV1 ADGRE2 PCDH17 RYR2 EYS FBN2 AGRN NOTCH1 PROS1 | 1.70e-05 | 749 | 98 | 14 | GO:0005509 |
| GeneOntologyMolecularFunction | chromatin-protein adaptor activity | 4.81e-05 | 41 | 98 | 4 | GO:0140463 | |
| GeneOntologyMolecularFunction | ubiquitin-modified protein reader activity | 1.23e-04 | 20 | 98 | 3 | GO:0140036 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein reader activity | 2.44e-04 | 25 | 98 | 3 | GO:0140035 | |
| GeneOntologyMolecularFunction | ubiquitin-modified histone reader activity | 4.93e-04 | 7 | 98 | 2 | GO:0061649 | |
| GeneOntologyMolecularFunction | insulin-like growth factor II binding | 6.55e-04 | 8 | 98 | 2 | GO:0031995 | |
| GeneOntologyBiologicalProcess | protein localization to site of double-strand break | 8.01e-07 | 16 | 97 | 4 | GO:1990166 | |
| GeneOntologyBiologicalProcess | regulation of double-strand break repair | 5.82e-06 | 146 | 97 | 7 | GO:2000779 | |
| GeneOntologyBiologicalProcess | regulation of glucocorticoid mediated signaling pathway | 2.19e-05 | 2 | 97 | 2 | GO:1900169 | |
| GeneOntologyBiologicalProcess | protein localization to M-band | 2.19e-05 | 2 | 97 | 2 | GO:0036309 | |
| GeneOntologyBiologicalProcess | negative regulation of double-strand break repair | 3.69e-05 | 40 | 97 | 4 | GO:2000780 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA repair | 4.49e-05 | 42 | 97 | 4 | GO:0045738 | |
| GeneOntologyBiologicalProcess | regulation of SA node cell action potential | 6.55e-05 | 3 | 97 | 2 | GO:0098907 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA metabolic process | 9.20e-05 | 155 | 97 | 6 | GO:0051053 | |
| GeneOntologyBiologicalProcess | regulation of DNA repair | 1.19e-04 | 234 | 97 | 7 | GO:0006282 | |
| GeneOntologyBiologicalProcess | regulation of atrial cardiac muscle cell action potential | 1.31e-04 | 4 | 97 | 2 | GO:0098910 | |
| GeneOntologyBiologicalProcess | glucocorticoid mediated signaling pathway | 1.31e-04 | 4 | 97 | 2 | GO:0043402 | |
| GeneOntologyBiologicalProcess | prolactin signaling pathway | 1.31e-04 | 4 | 97 | 2 | GO:0038161 | |
| GeneOntologyBiologicalProcess | protein localization to organelle | SLF1 POLR1A ANK2 LRRK2 OBSCN PEX6 NBN RYR2 NEDD4 ARFRP1 DCLK3 TNPO3 NOTCH1 TP53BP1 RAD17 | 1.69e-04 | 1091 | 97 | 15 | GO:0033365 |
| GeneOntologyBiologicalProcess | presynapse assembly | 1.83e-04 | 60 | 97 | 4 | GO:0099054 | |
| GeneOntologyBiologicalProcess | presynaptic active zone assembly | 2.17e-04 | 5 | 97 | 2 | GO:1904071 | |
| GeneOntologyBiologicalProcess | regulation of AV node cell action potential | 2.17e-04 | 5 | 97 | 2 | GO:0098904 | |
| GeneOntologyBiologicalProcess | DNA repair | DPF1 RNF169 SLF1 CHAF1A NBN FANCB HLTF HSF1 TOP3B TP53BP1 RAD17 | 2.32e-04 | 648 | 97 | 11 | GO:0006281 |
| GeneOntologyCellularComponent | site of double-strand break | 1.19e-04 | 101 | 99 | 5 | GO:0035861 | |
| Domain | EGF | STAB2 MATN4 TECTA ADGRE2 ITGB5 EYS FBN2 ASTN1 AGRN NOTCH1 PROS1 | 3.81e-08 | 235 | 97 | 11 | SM00181 |
| Domain | EGF_CA | 2.34e-07 | 122 | 97 | 8 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 2.65e-07 | 124 | 97 | 8 | IPR001881 | |
| Domain | EGF | 3.00e-07 | 126 | 97 | 8 | PF00008 | |
| Domain | EGF-like_dom | 6.74e-07 | 249 | 97 | 10 | IPR000742 | |
| Domain | EGF_1 | 8.37e-07 | 255 | 97 | 10 | PS00022 | |
| Domain | EGF-like_CS | 1.03e-06 | 261 | 97 | 10 | IPR013032 | |
| Domain | EGF_2 | 1.19e-06 | 265 | 97 | 10 | PS01186 | |
| Domain | Growth_fac_rcpt_ | 1.52e-06 | 156 | 97 | 8 | IPR009030 | |
| Domain | EGF_3 | 3.71e-06 | 235 | 97 | 9 | PS50026 | |
| Domain | ASX_HYDROXYL | 1.35e-05 | 100 | 97 | 6 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.88e-05 | 106 | 97 | 6 | IPR000152 | |
| Domain | Laminin_G_1 | 2.17e-05 | 11 | 97 | 3 | PF00054 | |
| Domain | EGF_CA | 8.51e-05 | 86 | 97 | 5 | PF07645 | |
| Domain | EGF_Ca-bd_CS | 1.50e-04 | 97 | 97 | 5 | IPR018097 | |
| Domain | DUF4195 | 1.59e-04 | 4 | 97 | 2 | IPR025243 | |
| Domain | DUF4195 | 1.59e-04 | 4 | 97 | 2 | PF13836 | |
| Domain | EGF_CA | 1.66e-04 | 99 | 97 | 5 | PS01187 | |
| Domain | BRCT | 1.95e-04 | 22 | 97 | 3 | SM00292 | |
| Domain | - | 2.23e-04 | 23 | 97 | 3 | 3.40.50.10190 | |
| Domain | BRCT | 3.24e-04 | 26 | 97 | 3 | PS50172 | |
| Domain | hEGF | 4.05e-04 | 28 | 97 | 3 | PF12661 | |
| Domain | BRCT_dom | 4.05e-04 | 28 | 97 | 3 | IPR001357 | |
| Domain | GPS | 8.56e-04 | 36 | 97 | 3 | PS50221 | |
| Domain | GPS | 9.28e-04 | 37 | 97 | 3 | IPR000203 | |
| Domain | LAM_G_DOMAIN | 1.00e-03 | 38 | 97 | 3 | PS50025 | |
| Domain | - | 1.52e-03 | 95 | 97 | 4 | 2.60.120.200 | |
| Domain | LamG | 1.54e-03 | 44 | 97 | 3 | SM00282 | |
| Domain | - | 1.86e-03 | 248 | 97 | 6 | 1.25.40.20 | |
| Domain | Ankyrin_rpt-contain_dom | 2.10e-03 | 254 | 97 | 6 | IPR020683 | |
| Domain | Laminin_G | 3.41e-03 | 58 | 97 | 3 | IPR001791 | |
| Domain | EGF_extracell | 3.75e-03 | 60 | 97 | 3 | IPR013111 | |
| Domain | EGF_2 | 3.75e-03 | 60 | 97 | 3 | PF07974 | |
| Domain | PP2C | 4.31e-03 | 19 | 97 | 2 | PF00481 | |
| Domain | BRCT | 4.31e-03 | 19 | 97 | 2 | PF00533 | |
| Domain | PP2Cc | 4.77e-03 | 20 | 97 | 2 | SM00332 | |
| Domain | - | 4.77e-03 | 20 | 97 | 2 | 3.60.40.10 | |
| Domain | PPM-type_phosphatase_dom | 4.77e-03 | 20 | 97 | 2 | IPR001932 | |
| Domain | PPM_2 | 4.77e-03 | 20 | 97 | 2 | PS51746 | |
| Pubmed | RNF169 limits 53BP1 deposition at DSBs to stimulate single-strand annealing repair. | 4.58e-07 | 6 | 100 | 3 | 30104380 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 21381019 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 30367460 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 38145746 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 37321467 | ||
| Pubmed | NEDD4-mediated HSF1 degradation underlies α-synucleinopathy. | 8.18e-06 | 2 | 100 | 2 | 26503960 | |
| Pubmed | Cerebellin-2 regulates a serotonergic dorsal raphe circuit that controls compulsive behaviors. | 8.18e-06 | 2 | 100 | 2 | 34158618 | |
| Pubmed | 1.52e-05 | 17 | 100 | 3 | 20856818 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 26482424 | ||
| Pubmed | Nuclear phosphoinositide 3-kinase beta controls double-strand break DNA repair. | 2.45e-05 | 3 | 100 | 2 | 20368419 | |
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 23853053 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 27005929 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 29691328 | ||
| Pubmed | Obscurin targets ankyrin-B and protein phosphatase 2A to the cardiac M-line. | 2.45e-05 | 3 | 100 | 2 | 18782775 | |
| Pubmed | Cerebellins are differentially expressed in selective subsets of neurons throughout the brain. | 2.45e-05 | 3 | 100 | 2 | 28714144 | |
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 28627598 | ||
| Pubmed | Two distinct modes of ATR activation orchestrated by Rad17 and Nbs1. | 2.45e-05 | 3 | 100 | 2 | 23684611 | |
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 22566688 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 12527750 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 31469403 | ||
| Pubmed | Notch is a direct negative regulator of the DNA-damage response. | 2.45e-05 | 3 | 100 | 2 | 25895060 | |
| Pubmed | Comparison of Cbln1 and Cbln2 functions using transgenic and knockout mice. | 2.45e-05 | 3 | 100 | 2 | 22117778 | |
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 35773961 | ||
| Pubmed | 3.92e-05 | 23 | 100 | 3 | 18001291 | ||
| Pubmed | 4.89e-05 | 4 | 100 | 2 | 22328512 | ||
| Pubmed | 4.89e-05 | 4 | 100 | 2 | 17331201 | ||
| Pubmed | 4.89e-05 | 4 | 100 | 2 | 21410790 | ||
| Pubmed | Distinct expression of Cbln family mRNAs in developing and adult mouse brains. | 4.89e-05 | 4 | 100 | 2 | 16930405 | |
| Pubmed | Replication independent ATR signalling leads to G2/M arrest requiring Nbs1, 53BP1 and MDC1. | 4.89e-05 | 4 | 100 | 2 | 18664457 | |
| Pubmed | Plakophilin 1 but not plakophilin 3 regulates desmoglein clustering. | 4.89e-05 | 4 | 100 | 2 | 30949721 | |
| Pubmed | 4.89e-05 | 4 | 100 | 2 | 22191730 | ||
| Pubmed | Cbln1 is essential for interaction-dependent secretion of Cbln3. | 4.89e-05 | 4 | 100 | 2 | 17030622 | |
| Pubmed | Atrx deficiency induces telomere dysfunction, endocrine defects, and reduced life span. | 5.07e-05 | 25 | 100 | 3 | 23563309 | |
| Pubmed | 8.14e-05 | 5 | 100 | 2 | 36205393 | ||
| Pubmed | 8.14e-05 | 5 | 100 | 2 | 25890304 | ||
| Pubmed | GKAP Acts as a Genetic Modulator of NMDAR Signaling to Govern Invasive Tumor Growth. | 8.14e-05 | 5 | 100 | 2 | 29606348 | |
| Pubmed | 8.14e-05 | 5 | 100 | 2 | 11500511 | ||
| Pubmed | Histone H2AX phosphorylation is dispensable for the initial recognition of DNA breaks. | 8.14e-05 | 5 | 100 | 2 | 12792649 | |
| Pubmed | Ubiquitin Phosphorylation at Thr12 Modulates the DNA Damage Response. | 8.14e-05 | 5 | 100 | 2 | 33022275 | |
| Pubmed | MDC1 regulates intra-S-phase checkpoint by targeting NBS1 to DNA double-strand breaks. | 8.14e-05 | 5 | 100 | 2 | 18678890 | |
| Pubmed | 53BP1 facilitates long-range DNA end-joining during V(D)J recombination. | 8.14e-05 | 5 | 100 | 2 | 18931658 | |
| Pubmed | 8.14e-05 | 5 | 100 | 2 | 24534091 | ||
| Pubmed | DPF1 DIS3L CHAF1A PEX6 NBN BRMS1L ZC3H3 FBN2 IGFBP1 ZFHX3 SIGLEC1 KAT6B | 8.80e-05 | 1116 | 100 | 12 | 31753913 | |
| Pubmed | 1.22e-04 | 6 | 100 | 2 | 11934988 | ||
| Pubmed | 1.22e-04 | 6 | 100 | 2 | 20525073 | ||
| Pubmed | NEDD4 controls the expression of GUCD1, a protein upregulated in proliferating liver cells. | 1.22e-04 | 6 | 100 | 2 | 24743017 | |
| Pubmed | 1.22e-04 | 6 | 100 | 2 | 28506460 | ||
| Pubmed | RNF8 ubiquitylates histones at DNA double-strand breaks and promotes assembly of repair proteins. | 1.22e-04 | 6 | 100 | 2 | 18001824 | |
| Pubmed | 1.22e-04 | 6 | 100 | 2 | 22492721 | ||
| Pubmed | Human variation in alcohol response is influenced by variation in neuronal signaling genes. | 1.40e-04 | 171 | 100 | 5 | 20201926 | |
| Pubmed | 1.70e-04 | 7 | 100 | 2 | 23471985 | ||
| Pubmed | 1.70e-04 | 7 | 100 | 2 | 36823038 | ||
| Pubmed | RNF8 transduces the DNA-damage signal via histone ubiquitylation and checkpoint protein assembly. | 1.70e-04 | 7 | 100 | 2 | 18001825 | |
| Pubmed | BRIT1 regulates early DNA damage response, chromosomal integrity, and cancer. | 1.70e-04 | 7 | 100 | 2 | 16872911 | |
| Pubmed | 1.70e-04 | 7 | 100 | 2 | 29782851 | ||
| Pubmed | Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. | 1.73e-04 | 283 | 100 | 6 | 18854154 | |
| Pubmed | ANK2 ZSWIM5 PKD1L1 KIAA0586 LRRK2 OBSCN CBLN1 FBN2 PPA2 AGRN TOP3B NOTCH1 | 1.94e-04 | 1215 | 100 | 12 | 15146197 | |
| Pubmed | Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. | 1.96e-04 | 39 | 100 | 3 | 19010793 | |
| Pubmed | 2.12e-04 | 101 | 100 | 4 | 18519826 | ||
| Pubmed | 53BP1 promotes ATM activity through direct interactions with the MRN complex. | 2.27e-04 | 8 | 100 | 2 | 20010693 | |
| Pubmed | 2.27e-04 | 8 | 100 | 2 | 16141228 | ||
| Pubmed | DYNLL1 binds to MRE11 to limit DNA end resection in BRCA1-deficient cells. | 2.27e-04 | 8 | 100 | 2 | 30464262 | |
| Pubmed | 2.91e-04 | 9 | 100 | 2 | 21356198 | ||
| Pubmed | 2.91e-04 | 9 | 100 | 2 | 15296947 | ||
| Pubmed | Insulin-like growth factor axis gene polymorphisms and clinical outcomes in pancreatic cancer. | 3.63e-04 | 10 | 100 | 2 | 20416304 | |
| Pubmed | Insulin-like growth factor axis gene polymorphisms modify risk of pancreatic cancer. | 3.63e-04 | 10 | 100 | 2 | 21852217 | |
| Pubmed | 3.63e-04 | 10 | 100 | 2 | 27320916 | ||
| Pubmed | 4.10e-04 | 50 | 100 | 3 | 23658023 | ||
| Pubmed | 4.43e-04 | 11 | 100 | 2 | 11790773 | ||
| Pubmed | IGFs increase enamel formation by inducing expression of enamel mineralizing specific genes. | 4.43e-04 | 11 | 100 | 2 | 15721138 | |
| Pubmed | 4.43e-04 | 11 | 100 | 2 | 7750499 | ||
| Pubmed | Synapse formation by hippocampal neurons from agrin-deficient mice. | 4.43e-04 | 11 | 100 | 2 | 9882498 | |
| Pubmed | 4.43e-04 | 11 | 100 | 2 | 12607005 | ||
| Pubmed | Role of genomic instability and p53 in AID-induced c-myc-Igh translocations. | 4.43e-04 | 11 | 100 | 2 | 16400328 | |
| Pubmed | 4.43e-04 | 11 | 100 | 2 | 20081839 | ||
| Pubmed | 4.43e-04 | 11 | 100 | 2 | 27452274 | ||
| Pubmed | 4.60e-04 | 52 | 100 | 3 | 22219177 | ||
| Pubmed | Calcium signaling induces partial EMT and renal fibrosis in a Wnt4mCherry knock-in mouse model. | 4.87e-04 | 53 | 100 | 3 | 38653356 | |
| Pubmed | 5.14e-04 | 54 | 100 | 3 | 36237976 | ||
| Pubmed | 5.30e-04 | 12 | 100 | 2 | 19693543 | ||
| Pubmed | 5.30e-04 | 12 | 100 | 2 | 15149599 | ||
| Pubmed | BRCA2 mediates centrosome cohesion via an interaction with cytoplasmic dynein. | 6.03e-04 | 57 | 100 | 3 | 27433848 | |
| Pubmed | Genomic structure and mapping of precerebellin and a precerebellin-related gene. | 6.25e-04 | 13 | 100 | 2 | 7877445 | |
| Pubmed | 6.25e-04 | 13 | 100 | 2 | 35741102 | ||
| Pubmed | A Human Hereditary Cardiomyopathy Shares a Genetic Substrate With Bicuspid Aortic Valve. | 6.25e-04 | 13 | 100 | 2 | 36325906 | |
| Pubmed | 6.25e-04 | 13 | 100 | 2 | 18722365 | ||
| Pubmed | 6.39e-04 | 503 | 100 | 7 | 16964243 | ||
| Pubmed | 7.28e-04 | 14 | 100 | 2 | 26123487 | ||
| Pubmed | Perp is a p63-regulated gene essential for epithelial integrity. | 7.28e-04 | 14 | 100 | 2 | 15797384 | |
| Pubmed | 7.35e-04 | 61 | 100 | 3 | 20634197 | ||
| Pubmed | 7.71e-04 | 62 | 100 | 3 | 19463158 | ||
| Pubmed | Desmosomal localization of beta-catenin in the skin of plakoglobin null-mutant mice. | 8.39e-04 | 15 | 100 | 2 | 9847250 | |
| Pubmed | p63 control of desmosome gene expression and adhesion is compromised in AEC syndrome. | 8.39e-04 | 15 | 100 | 2 | 23108156 | |
| Pubmed | 8.39e-04 | 15 | 100 | 2 | 21135503 | ||
| Pubmed | 8.46e-04 | 64 | 100 | 3 | 22261194 | ||
| Pubmed | 9.22e-04 | 149 | 100 | 4 | 25184681 | ||
| Pubmed | Desmocollin 3 is required for pre-implantation development of the mouse embryo. | 9.57e-04 | 16 | 100 | 2 | 16418220 | |
| Pubmed | 9.57e-04 | 16 | 100 | 2 | 30689641 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 9.91e-04 | 394 | 100 | 6 | 27248496 | |
| Pubmed | 1.08e-03 | 17 | 100 | 2 | 11781569 | ||
| Cytoband | 22q11.22 | 1.72e-05 | 23 | 100 | 3 | 22q11.22 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | DPF1 DIP2B ANK2 PCLO LRRK2 GPRIN3 PCDH17 RYR2 SGK2 CREBRF ASXL3 CBLN2 DCLK3 ZFHX3 KIF13A PRLR | 4.35e-06 | 1106 | 100 | 16 | M39071 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.05e-05 | 196 | 100 | 7 | M3008 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.07e-09 | 184 | 100 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.07e-09 | 184 | 100 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.07e-09 | 184 | 100 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.38e-07 | 189 | 100 | 7 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-07 | 189 | 100 | 7 | 38acb307907fde68b992057714448c1561d69ee3 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.55e-07 | 191 | 100 | 7 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.64e-07 | 192 | 100 | 7 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.64e-07 | 192 | 100 | 7 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.74e-07 | 193 | 100 | 7 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.84e-07 | 194 | 100 | 7 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV-2|World / Primary Cells by Cluster | 3.37e-07 | 199 | 100 | 7 | f09b40245d3d826275bbe5f508dedccc75a911bd | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV|World / Primary Cells by Cluster | 3.37e-07 | 199 | 100 | 7 | e45448ec4db8875c8aaa9aad109a10e2905a4226 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 6.17e-07 | 135 | 100 | 6 | b128596653a5e3b64ed7f657bbfeda35438e2e48 | |
| ToppCell | COVID-19_Mild|World / 5 Neutrophil clusters in COVID-19 patients | 1.24e-06 | 152 | 100 | 6 | 2ff0980dfd8d430cca14649151d856edef115720 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-06 | 160 | 100 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-06 | 160 | 100 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.99e-06 | 177 | 100 | 6 | bd602db857f37869ef76d14c05ef522c509f08ee | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CACNG5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.74e-06 | 184 | 100 | 6 | 658f2e522055e88c92bc482a845c40f8f5f1a8e3 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.85e-06 | 185 | 100 | 6 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.98e-06 | 186 | 100 | 6 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 4.10e-06 | 187 | 100 | 6 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.36e-06 | 189 | 100 | 6 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.36e-06 | 189 | 100 | 6 | 6f0fc5271a7d3682f145e734abc3be6473dda2e2 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.36e-06 | 189 | 100 | 6 | 3b9ce8964b16cb2200d30cbb0bfc711dcad2380e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.49e-06 | 190 | 100 | 6 | 59bbbd2c8d4b7ce46c54ca8022b1557e7e5eee2a | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-06 | 190 | 100 | 6 | 96a92212ea3fb35fa3d0da495e504edc61c71c23 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.63e-06 | 191 | 100 | 6 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-06 | 191 | 100 | 6 | 3387b95a3f2445c672d407922fdce3a91eabaef8 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.77e-06 | 192 | 100 | 6 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.77e-06 | 192 | 100 | 6 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.77e-06 | 192 | 100 | 6 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.77e-06 | 192 | 100 | 6 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.77e-06 | 192 | 100 | 6 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 4.92e-06 | 193 | 100 | 6 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.06e-06 | 194 | 100 | 6 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.06e-06 | 194 | 100 | 6 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | T_cells-CD56_dim_CD16+_NK_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 5.37e-06 | 196 | 100 | 6 | 07b557b8530c19ca5b31ad2eac00c36ef1939266 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area|World / Primary Cells by Cluster | 5.53e-06 | 197 | 100 | 6 | 79b9e7f2e8e33b3c547f716be5667156c48b0dfc | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area-33|World / Primary Cells by Cluster | 5.53e-06 | 197 | 100 | 6 | d20f29088e9afd8a960d6f680075c380e550f8a7 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Adventitial_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.86e-06 | 199 | 100 | 6 | 8de6d7b2067b22cb9b5f01aa56a3803aebc4406d | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.86e-06 | 199 | 100 | 6 | bbb4798d6a24e756fea744a151ba67c1bafbac9a | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.86e-06 | 199 | 100 | 6 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 6.03e-06 | 200 | 100 | 6 | 61d7dd0a78942b069c3f5e75044368dc00e6e8e6 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2.Synpr-Pcdh11x_(Neuron.Gad1Gad2.Synpr-Pcdh11x)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 9.52e-06 | 59 | 100 | 4 | 439a9d56eeecccd70a4defb430e228329655cb80 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2.Synpr-Pcdh11x_(Neuron.Gad1Gad2.Synpr-Pcdh11x)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 9.52e-06 | 59 | 100 | 4 | 50432c7b52fd197e8856ba0296c34cf66a2faaf5 | |
| ToppCell | Severe-B_intermediate-14|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.73e-05 | 142 | 100 | 5 | 9c7d5783302974b883bd887f997d094eb5925ec2 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.63e-05 | 155 | 100 | 5 | d10cf5e922dbd3ca46660404da5aca43f181fc19 | |
| ToppCell | Children_(3_yrs)-Immune-mast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.80e-05 | 157 | 100 | 5 | ec185dbeabb67fd9ca85f71cab88463b60f9b1c1 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-05 | 160 | 100 | 5 | 56e6f4b82b5dc41c45f9d253c2db314a6f702b84 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-05 | 160 | 100 | 5 | bb1b966fb9e801db15e67d03e49db4609d6f935a | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-05 | 161 | 100 | 5 | 60f433eab9d5531bdf6aa86b0265f20b866b904c | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.09e-05 | 170 | 100 | 5 | ba4ba66b624089ed50a9083176386c7941b4c7a3 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-05 | 173 | 100 | 5 | a5172dee859bf6c2eed46c48bd64dfef0ff9f28f | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-05 | 173 | 100 | 5 | 639b5b0b33ce5aa0bc26363c059717012ddc14c0 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.70e-05 | 175 | 100 | 5 | 65571d775d26a40e979dbf290a8e4320c0d9fb3f | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Penk_Fst|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.82e-05 | 176 | 100 | 5 | a1b9f8f199a028b3fa85de43fe96bc29f387bfd8 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Endothelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.82e-05 | 176 | 100 | 5 | 27e5115fae5f0f63b333bc99fbf6a6d4c9182c46 | |
| ToppCell | normal_Lung-Endothelial_cells-EPCs|normal_Lung / Location, Cell class and cell subclass | 4.82e-05 | 176 | 100 | 5 | 71d1bd425772d89d8c550b909e0ec0e36ff22a7e | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_postreplicative-neuro_migrating_neuronal_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.09e-05 | 178 | 100 | 5 | 38ffbd01230c99f52274424ee6c172381daffc73 | |
| ToppCell | -Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 5.23e-05 | 179 | 100 | 5 | e4224b2e9c4ae7da62cf670adf811f4112c7d060 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.23e-05 | 179 | 100 | 5 | a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.37e-05 | 180 | 100 | 5 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_B-Branch_B2_(eMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.37e-05 | 180 | 100 | 5 | 368ff7fcfd21ad248f96a83a8b191040ba7d8670 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-neurons_A-Branch_A4_(IN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.51e-05 | 181 | 100 | 5 | fb4df9a128761abe5c6310a30d7b2f7f2fdef46d | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.51e-05 | 181 | 100 | 5 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | droplet-Heart-4Chambers-18m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.66e-05 | 182 | 100 | 5 | 6fdaf3c8c3952a8f14dd7288e523ed58eb1d3517 | |
| ToppCell | droplet-Heart-4Chambers-21m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.80e-05 | 183 | 100 | 5 | 4de2082dca2569d3aac3c9b466f27971c82d302b | |
| ToppCell | droplet-Heart-4Chambers-21m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.80e-05 | 183 | 100 | 5 | a046b569bc10083d471b420eb2c6fee93437602d | |
| ToppCell | (2)_5-FU-(4)_COL2.3+_osteoblasts|World / Stress and Cell class | 5.96e-05 | 184 | 100 | 5 | 684d05340a3dfb8aa08b881516a37f9627a10448 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.11e-05 | 185 | 100 | 5 | 8ed10ba581849c9c4ac4397226be2b62b4b3b900 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.11e-05 | 185 | 100 | 5 | b4af9ae4c358b48357cb135b740266e1652d886a | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.11e-05 | 185 | 100 | 5 | b8052cebb73f41abe6faf0aa847be7c8ef23ae94 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.27e-05 | 186 | 100 | 5 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.27e-05 | 186 | 100 | 5 | 4d68ee3d32f7ef884faf402ef92b31b0eb4656f1 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.43e-05 | 187 | 100 | 5 | 5258674d0346e5c51a4b965efcdc1790c970845d | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.59e-05 | 188 | 100 | 5 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 6.76e-05 | 189 | 100 | 5 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | moderate-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.76e-05 | 189 | 100 | 5 | 6011b747e27d61d222380a7bffdd921a68e9b657 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.76e-05 | 189 | 100 | 5 | f01158bb15df3117fae1271bf8cf8c2501422671 | |
| ToppCell | AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 6.76e-05 | 189 | 100 | 5 | 2d32f09efa982ae458568f6b1cd06bb5078d42a3 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 6.76e-05 | 189 | 100 | 5 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.93e-05 | 190 | 100 | 5 | 841cd55861b43578d704418b9bc0af2e8b88323a | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.93e-05 | 190 | 100 | 5 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | ASK454-Mesenchymal|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.11e-05 | 191 | 100 | 5 | e30ae7a12439f8a79820b13f03e822c1223fd0cb | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.11e-05 | 191 | 100 | 5 | fa380a8752de158974b2ae5e741573439719cc0d | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.11e-05 | 191 | 100 | 5 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.11e-05 | 191 | 100 | 5 | 44b1f62fdee03b157fe545f2ae6ff84f8929a8ac | |
| ToppCell | ASK454-Mesenchymal-Fibroblast|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.11e-05 | 191 | 100 | 5 | 1726add3f392a061536b7aff72ba84303f4a0b1f | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.11e-05 | 191 | 100 | 5 | c7b95a5f9185d533c08754ce2e4ce91533eb612e | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.11e-05 | 191 | 100 | 5 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.28e-05 | 192 | 100 | 5 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.28e-05 | 192 | 100 | 5 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | facs-Lung-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.28e-05 | 192 | 100 | 5 | 8df15085b35b86f39debd933284cb703c5dd63c2 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.28e-05 | 192 | 100 | 5 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neuron_precursor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.28e-05 | 192 | 100 | 5 | 56f2388c9c4e19883ae5cff332c77f596ff744a8 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.46e-05 | 193 | 100 | 5 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.46e-05 | 193 | 100 | 5 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-kidney_distal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.46e-05 | 193 | 100 | 5 | fa8bcf2a5ab7b08fae98a1466a936995142b4309 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.65e-05 | 194 | 100 | 5 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.65e-05 | 194 | 100 | 5 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| Drug | Glimepiride [93479-97-1]; Up 200; 8.2uM; PC3; HT_HG-U133A | 1.61e-07 | 194 | 98 | 9 | 6628_UP | |
| Drug | Eserine sulfate, physostigmine sulfate [64-47-1]; Up 200; 6.2uM; HL60; HG-U133A | 2.20e-06 | 197 | 98 | 8 | 1776_UP | |
| Drug | Rapamycin; Up 200; 0.1uM; HL60; HT_HG-U133A | 2.20e-06 | 197 | 98 | 8 | 6180_UP | |
| Drug | (-) -Levobunolol hydrochloride [27912-14-7]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 2.10e-05 | 194 | 98 | 7 | 4134_DN | |
| Drug | Parbendazole [14255-87-9]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 2.25e-05 | 196 | 98 | 7 | 4357_UP | |
| Drug | Flunarizine dihydrochloride [30484-77-6]; Down 200; 8.4uM; HL60; HT_HG-U133A | 2.40e-05 | 198 | 98 | 7 | 2381_DN | |
| Drug | Diphenylpyraline hydrochloride [132-18-3]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 2.48e-05 | 199 | 98 | 7 | 3640_UP | |
| Drug | troglitazone; Up 200; 10uM; HL60; HT_HG-U133A | 2.48e-05 | 199 | 98 | 7 | 6191_UP | |
| Disease | colorectal health | 6.14e-05 | 201 | 99 | 6 | EFO_0008460 | |
| Disease | TNF-related apoptosis-inducing ligand measurement | 1.03e-04 | 72 | 99 | 4 | EFO_0008300 | |
| Disease | atopy | 1.11e-04 | 5 | 99 | 2 | EFO_0002686 | |
| Disease | Malignant neoplasm of breast | FNDC3B ANK2 ZSWIM5 OBSCN NBN TECTA NEDD4 OR1N1 ARFRP1 KAT6B NOTCH1 TP53BP1 | 2.55e-04 | 1074 | 99 | 12 | C0006142 |
| Disease | intraocular pressure measurement | 3.22e-04 | 509 | 99 | 8 | EFO_0004695 | |
| Disease | Abnormality of refraction | 4.42e-04 | 673 | 99 | 9 | HP_0000539 | |
| Disease | rheumatoid arthritis, systemic lupus erythematosus | 4.93e-04 | 10 | 99 | 2 | EFO_0000685, MONDO_0007915 | |
| Disease | VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder) | 4.93e-04 | 10 | 99 | 2 | C1631597 | |
| Disease | Primary biliary cirrhosis | 5.34e-04 | 47 | 99 | 3 | C0008312 | |
| Disease | facial morphology measurement | 1.00e-03 | 466 | 99 | 7 | EFO_0007841 | |
| Disease | Schizoaffective disorder-bipolar type | 1.30e-03 | 16 | 99 | 2 | EFO_0009965 | |
| Disease | polychlorinated biphenyls measurement | 1.38e-03 | 65 | 99 | 3 | EFO_0007042 | |
| Disease | S-6-hydroxywarfarin measurement | 1.53e-03 | 368 | 99 | 6 | EFO_0803326 | |
| Disease | diastolic blood pressure, systolic blood pressure | 1.90e-03 | 670 | 99 | 8 | EFO_0006335, EFO_0006336 | |
| Disease | corneal hysteresis | 2.04e-03 | 20 | 99 | 2 | EFO_0010066 | |
| Disease | intellectual disability (implicated_via_orthology) | 2.08e-03 | 75 | 99 | 3 | DOID:1059 (implicated_via_orthology) | |
| Disease | haptoglobin measurement | 2.24e-03 | 21 | 99 | 2 | EFO_0004640 | |
| Disease | wellbeing measurement | 2.31e-03 | 692 | 99 | 8 | EFO_0007869 | |
| Disease | brain connectivity measurement | 2.32e-03 | 400 | 99 | 6 | EFO_0005210 | |
| Disease | unipolar depression | CASP8AP2 BNC2 DLGAP1 PCLO PCDHA6 BRMS1L ADGRE2 IHO1 ASXL3 ASTN1 ZFHX3 | 2.39e-03 | 1206 | 99 | 11 | EFO_0003761 |
| Disease | vital capacity | DIP2B BNC2 PCLO PKDCC GPRIN3 PCDHA6 ADAMTS8 ODAD2 RYR2 SYT14 ZFHX3 | 2.89e-03 | 1236 | 99 | 11 | EFO_0004312 |
| Disease | prostate carcinoma | 3.08e-03 | 891 | 99 | 9 | EFO_0001663 | |
| Disease | skin aging measurement | 3.28e-03 | 181 | 99 | 4 | EFO_0008006 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PESLSCNKALCASDV | 21 | Q9GZX9 | |
| GPSAVCKICELSFET | 361 | P59817 | |
| PSTVCKICELSFETD | 371 | Q86YH2 | |
| PSDCGEKVTLCISVL | 266 | P32297 | |
| EDPKLCTDVNECTSG | 156 | Q9UHX3 | |
| APDSCKVDGCILTTQ | 286 | Q8N6M5 | |
| KVPCCGVDTSQIESE | 31 | Q6ZN30 | |
| CSSKTLQAEVPLSDC | 186 | Q8IUR6 | |
| DIGTICDPNKSCSVI | 336 | Q9UP79 | |
| SKKTGCPEDLISCAD | 281 | Q92782 | |
| LTCPEANATKVCGSD | 926 | O00468 | |
| PICSTTGDDKLCADS | 651 | Q12802 | |
| CIPEIAEEGSTISCV | 1581 | Q8WXG9 | |
| DVKCSTCANLPVSLD | 256 | O14490 | |
| LSDIPCKTEEEGVGC | 176 | Q13111 | |
| LETLKCESIPACTTE | 1346 | Q9UKL3 | |
| CESIPACTTEELVSG | 1351 | Q9UKL3 | |
| ISDRKLDSTGCVCPS | 626 | O14525 | |
| SSCPADGTLDLVCES | 86 | Q9C0F0 | |
| PATCSVKGSEICLEE | 1106 | Q8TBY9 | |
| KACIEPCTSTKGSLD | 1041 | O14917 | |
| SCDAGPLLKISCSDT | 176 | Q9NZP2 | |
| VPDKTSLELLCQGCS | 316 | O75943 | |
| ACTADKPTLVCSSAV | 731 | Q9UN73 | |
| DCGVDLTASCNSEPK | 1476 | Q8WYB5 | |
| DCTGSCSVALAKETP | 2326 | Q01484 | |
| NCPTAVLEKDAVCSS | 491 | P32926 | |
| CSEDKKSPSECSLIA | 1646 | Q9ULH0 | |
| ASSPCDSGTCLDKID | 646 | P46531 | |
| ISAGTELRSPCECES | 571 | O95460 | |
| KGSFCTETVSTCDPE | 2641 | Q5T1H1 | |
| ATLDCETTNGDCKPE | 386 | P46934 | |
| SDLNLGCSETPLCKE | 561 | Q8IYA8 | |
| ETETPKSCSEVAGCK | 56 | Q9C098 | |
| PTSTPEKCLSVACLD | 366 | Q00613 | |
| ESTCPLCKTELNIGS | 1056 | Q9Y6V0 | |
| EKLALCPPVSASCSE | 36 | P08833 | |
| LLKVPCSSLCAESSG | 491 | Q13608 | |
| PQLCKTDEIGEICVS | 741 | Q9P265 | |
| GSSLICQVCEKESSP | 741 | Q5S007 | |
| EPSTCKTDTLGLSCG | 686 | Q9Y4W2 | |
| SEPDALLVKSTEGCC | 111 | Q05215 | |
| LLVKSTEGCCAEPSA | 116 | Q05215 | |
| GSATSCEECLLIHPK | 31 | P18084 | |
| LALKDSPATCICSLD | 336 | Q9H7L2 | |
| SLCSEPLIELCSSGA | 111 | A2A3N6 | |
| VNCSTDCPSSEKIAL | 51 | P32942 | |
| NTSSAEEKECLVPLC | 436 | Q8NB91 | |
| EDLTLVCETSTCDIP | 3111 | Q5VST9 | |
| CLSIPDIKTAFSDCT | 141 | Q13795 | |
| EGKCLVVCDSNPTSD | 31 | P23435 | |
| SNTEGKSCPSEVLVC | 551 | Q53EP0 | |
| KDGLVISCGPDSCSE | 906 | Q8TF46 | |
| LSSIKCCVEEGLEPV | 16 | P49326 | |
| EGKCLVVCDSSPSAD | 61 | Q8IUK8 | |
| CTSSAAPVVKTVEDC | 16 | Q86UD3 | |
| SKDCGPDNECVTDLV | 786 | O75578 | |
| GQTICIDKKDECPTS | 271 | Q5PSV4 | |
| CKAIPPDSEKSISIC | 306 | Q8IYX8 | |
| SDEECAICLDSLTVP | 756 | Q14527 | |
| GTSCIDLDECSQSPK | 2486 | P35556 | |
| DPDCKLSDSCGSISK | 506 | Q6ZVF9 | |
| TDDVISCCLDLSAPS | 751 | Q92736 | |
| LGCKHPVLSTLCEES | 261 | P0C7U9 | |
| CGDNGLSETKELSCP | 1821 | Q8TDX9 | |
| SSSCSIPDCAGEVEK | 2231 | Q8TDX9 | |
| LRKDTESCTSPCLLG | 1476 | Q5THK1 | |
| FCDITPVLKLSCSDT | 176 | Q8NGS0 | |
| TGSCSELDACPSKIS | 1696 | Q9H1H9 | |
| CSEDIECSGLTIPKA | 236 | Q13835 | |
| VCGKLSSDVCPTSDK | 1261 | P11717 | |
| STFDGVTDKPILDCC | 186 | Q9HCB6 | |
| HLSCTPSEIGDSKCE | 176 | Q8NB59 | |
| GPADSKEVCSTCVQD | 56 | O95602 | |
| VEETPCAGSTDCILE | 301 | Q504Y2 | |
| CKEGVEPEDTTSTFC | 181 | Q9HBY8 | |
| EPLVACSSCLDVSGK | 111 | O60934 | |
| LVKPHDGETLCITCS | 251 | Q5T2S8 | |
| ETTLDSCQCKLPSSE | 156 | Q14714 | |
| EGSCTCSFPTSELEK | 561 | Q9NWF9 | |
| CCISLLTESSLKPTD | 191 | P49221 | |
| STEIPLETCCSSELK | 521 | Q8NCN4 | |
| DPIDVCEIGSKILSC | 166 | Q9H2U2 | |
| DVDECSLKPSICGTA | 201 | P07225 | |
| ETLTLGPICVDSCSE | 1001 | O75443 | |
| CVECESGVLVLDPTS | 726 | O95985 | |
| GTCSVEDPLLVCQKE | 181 | Q8IXZ2 | |
| DPQSCALSALTLCEK | 961 | Q9P217 | |
| CELEECGKASPVSSS | 281 | Q96MU6 | |
| LCTVETPASEICAGE | 66 | Q6ZVD8 | |
| RGSCDSPSLLSEKCE | 351 | P16471 | |
| SPSTEDENKLECKCL | 211 | Q8WWQ8 | |
| LIDPDAATCETSTCA | 1691 | Q9BZZ2 | |
| SCEPLEGVEKCSDSQ | 771 | Q12888 | |
| EGELSCSKENCPSVV | 781 | Q9BQI6 | |
| DGQCTSISPLKELVC | 86 | Q6X4U4 | |
| ELCETFLEKIVCTPG | 301 | Q9Y5L0 | |
| CSPRETCVEVASELG | 111 | O43915 | |
| LEIVDKGSVSCPTCQ | 161 | Q96ME7 | |
| KECVLVKTPDSSPCD | 1056 | Q9BVV6 | |
| PEVKSCDSFVCEVGL | 116 | Q8NDP4 | |
| ECPKCDTVLGSSRSL | 641 | Q15911 | |
| GTTLPCSICKHEIDL | 61 | A8MPX8 |